The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes

NCT03249259 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Choline alfoscerate
DRUG: Placebo

Sponsor

Seoul National University Bundang Hospital